[
  {
    "ts": null,
    "headline": "Is Gilead Sciences (GILD) Pricing Reflecting Recent 38.5% One Year Share Return?",
    "summary": "If you are wondering whether Gilead Sciences is fairly priced or offering value right now, this article will walk through what the numbers actually say about the stock. The share price recently closed at US$121.10, with returns of 0.6% over 30 days and 38.5% over 1 year. This may change how investors think about both upside and risk. Recent attention on Gilead has focused on its position in pharmaceuticals and biotech, as investors reassess major sector names in light of product pipelines,...",
    "url": "https://finnhub.io/api/news?id=7abed646326514a8ab42ec8a149ca4c51e3868757462e36cacaa9d4388e2d3b7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768147883,
      "headline": "Is Gilead Sciences (GILD) Pricing Reflecting Recent 38.5% One Year Share Return?",
      "id": 138069116,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "If you are wondering whether Gilead Sciences is fairly priced or offering value right now, this article will walk through what the numbers actually say about the stock. The share price recently closed at US$121.10, with returns of 0.6% over 30 days and 38.5% over 1 year. This may change how investors think about both upside and risk. Recent attention on Gilead has focused on its position in pharmaceuticals and biotech, as investors reassess major sector names in light of product pipelines,...",
      "url": "https://finnhub.io/api/news?id=7abed646326514a8ab42ec8a149ca4c51e3868757462e36cacaa9d4388e2d3b7"
    }
  }
]